Clinical Trial Update: Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia [Phase 3]

View source ↗

Summary

Phase 3 trial update on Cerebrolycin for treatment of Covid-19 related anosmia and ageusia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Related Ageusia
• COVID-19 Related Anosmia

Drugs mentioned

• Cerebrolycin (Cerebrolysin)

Snippet

Sponsor: Assiut University | Conditions: Covid19 Related Anosmia and Aguesia | Phase 3 | Status: COMPLETED